Drug Profile
AGX 101
Alternative Names: AGX-101; Anti-TM4SF1 ADC; Anti-TM4SF1 antibody-drug conjugate - Angiex; Antibody-drug conjugate - AngiexLatest Information Update: 08 Nov 2023
Price :
$50
*
At a glance
- Originator Angiex
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Surface antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer